Chiral Screening for SFC and UHPLC with the Agilent 1260 Infinity II SFC/UHPLC Hybrid System

Similar documents
Chiral Multicolumn Method Development on the Agilent 1260 Infinity II SFC System

Analysis of Vitamins Using an SFC/UHPLC Hybrid System with a Triple Quadrupole LC/MS for Quantification

Performance Characteristics of the Agilent 1290 Infinity II Multicolumn Thermostat

Application Note. Small Molecule Pharmaceuticals. 2-Ethyl-2-phenylmalonamide Ethosuximide Primidone Carbamazepine. Carbamazepine-

Separation of Polyphenols by Comprehensive 2D-LC and Molecular Formula Determination by Coupling to Accurate Mass Measurement

Maximizing chromatographic peak capacity with the Agilent 1290 Infinity LC system

2D-LC as an Automated Desalting Tool for MSD Analysis

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

Transferring a Method for Analysis of DNPH-Derivatized Aldehydes and Ketones from HPLC to UHPLC

Maximizing Efficiency Using Agilent InfinityLab Poroshell 120 Columns

Effective use of Pharmacopeia guidelines to reduce cost of chromatographic analysis for Fluticasone propionate

Qualitative and quantitative determination of phenolic antioxidant compounds in red wine and fruit juice with the Agilent 1290 Infinity 2D-LC Solution

Agilent 1260 Infinity Analytical Hybrid SFC/UHPLC system

Analysis of Counterfeit Antidiabetic Drugs by UHPLC with the Agilent 1220 Infinity Mobile LC

Increasing resolution using longer columns while maintaining analysis time Advantages of the wide power range of the Agilent 1290 Infinity LC System

Agilent 1260 Infinity Analytical SFC System

HPLC to UHPLC Transfer of USP Method for Amlodipine Besylate Using the Agilent 1290 Infinity II LC

Analytical Method Development for USP Related Compounds in Paclitaxel Using an Agilent Poroshell 120 PFP

LC/MS/MS Separation of Cholesterol and Related Sterols in Plasma on an Agilent InfinityLab Poroshell 120 EC C18 Column

Analysis of Amino Acids Derived Online Using an Agilent AdvanceBio AAA Column

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

HPLC Analysis with Fluorescence Detection of Chlorophyll Degradation Products Pheophytins and Pyropheophytin in Virgin Olive Oil

Online 2D-LC Analysis of Complex N-Glycans in Biopharmaceuticals Using the Agilent 1290 Infinity 2D-LC Solution

Performance characteristics of the Agilent 1100 Series preparative pump. Technical Note. Abstract

Application Note. Agilent Application Solution Analysis of fat-soluble vitamins from food matrix for nutrition labeling. Abstract.

Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection

Analysis of Antioxidants in Vegetable Oils Using the Agilent 1260 Infinity Hybrid SFC/UHPLC System with MS Detection

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

Rapid Gradient and Elevated Temperature UHPLC of Flavonoids in Citrus Fruit

Edgar Naegele. Abstract

Selectivity Comparison of Agilent Poroshell 120 Phases in the Separation of Butter Antioxidants

Comparison of a UPLC Method across Multiple UHPLC Systems

Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system

Small Scale Preparative Isolation of Corticosteroid Degradation Products Using Mass-Based Fraction Collection Application

High-Resolution Analysis of Intact Triglycerides by Reversed Phase HPLC Using the Agilent 1290 Infinity LC UHPLC System

Quantitative Analysis of Underivatized Amino Acids in Plant Matrix by Hydrophilic Interaction Chromatography (HILIC) with LC/MS Detection

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

Ultrafast analysis of synthetic antioxidants in vegetable oils using the Agilent 1290 Infinity LC system

Analysis of mycotoxins in food matrices using the Agilent Ultivo Triple Quadrupole LC/MS

Application Note. Abstract. Authors. Pharmaceutical

Identification of Steroids in Water by Ion Trap LC/MS/MS Application

Application Note. Abstract. Author. Biotherapeutics & Biosimilars. Sonja Schneider Agilent Technologies, Inc. Waldbronn, Germany

Profiling of Endogenous Metabolites Using Time-of-Flight LC/MS with Ion Pair Reverse Phase Chromatography

Converting a CHP Method for Insulin to Agilent Poroshell 120 Columns

Application Note. Authors. Abstract. Petrochemical

Am I getting the very best value from my UHPLC analyses?

InfinityLab Purification Capillary Kits

USP purity analysis of pravastatin sodium using the Agilent 1120 Compact LC

Two-Dimensional LC/MS/MS to Reduce Ion Suppression in the Determination of Cannabinoids in Blood Plasma

High Resolution Glycopeptide Mapping of EPO Using an Agilent AdvanceBio Peptide Mapping Column

Mycotoxin Analysis in Peanut Butter Using Captiva EMR Lipid Cleanup and LC/MS/MS

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

Simultaneous Analysis of Active Pharmaceutical Ingredients and Their Counter-Ions Using a Mixed-Mode Column

Rapid and sensitive UHPLC screening for water soluble vitamins in sports beverages

Extended Application Note

Lipidomic Analysis by UPLC-QTOF MS

Optimizing Chiral Separations and Purification of Enantiomers Through Selective Sample Slicing and Column Switching

Fast determination of residual glycerol and glycerides in biodiesel by SFC/MS using the Agilent 1260 Infinity Analytical SFC System

Agilent 1220 Infinity LC System Performance Specifications

Authors. Abstract. Introduction. Environmental

Quality Analysis of Extra Virgin Olive Oils Part 7

LC/MS Method for Comprehensive Analysis of Plasma Lipids

Analysis of bisphenol A leaching from baby feeding bottles

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics

Authors. Abstract. Forensic Toxicology. Irina Dioumaeva, John M. Hughes Agilent Technologies, Inc.

Reduced Ion Suppression and Improved LC/MS Sensitivity with Agilent Bond Elut Plexa

Determination of enantiomeric purity of Timolol Maleate by Supercritical Fluid Chromatography

Separation of 15 Underivatized Saccharide and Sialic Acid USP Standards

Analyze Barbiturates in Urine with Agilent 6430 LC/MS/MS and Poroshell 120 EC-C18

Using Software Tools to Improve the Detection of Impurities by LC/MS. Application Note. Christine Miller Agilent Technologies.

Enhanced method development workflow for modern LC and SFC

Rapid and sensitive UHPLC screening of additives in carbonated beverages with a robust organic acid column

COSMOSIL CHiRAL Series

STANDARD OPERATING PROTOCOL (SOP)

[ APPLICATION NOTE ] The Separation of 8 -THC, 9 -THC, and Their Enantiomers by UPC 2 Using Trefoil Chiral Columns INTRODUCTION APPLICATION BENEFITS

Modified QuEChERS for HILIC LC/MS/MS Analysis of Nicotine and Its Metabolites in Fish

Improving Coverage of the Plasma Lipidome Using Iterative MS/MS Data Acquisition Combined with Lipid Annotator Software and 6546 LC/Q-TOF

LC-MS/MS analysis of Chlorates in Milk and Whey Powder using the Agilent 6470 QQQ

Application Note. Authors: C. Ledesma, M. Gibert, J.R. Gibert Ingenieria Analitica S.L. Extracts from various food products

The LC Column Playbook

Enantiomeric and Diastereoisomeric Resolutions of Chiral Triazole Fungicides using Lux Polysaccharide-Based Chiral Stationary Phases

Forensic Analysis of Blood Alcohol Concentration

Mycotoxin Analysis in Infant Formula Using Captiva EMR Lipid Cleanup and LC/MS/MS

Analysis of Cholesterol-Lowering Drugs (Statins) Using Dried Matrix Spot Technology

Sue D Antonio Application Chemist Cedar Creek, TX

Pesticide Analysis using an Agilent 1290 Infinity LC System with an Agilent 6140 Single Quadrupole LC/MS System

Doubling the throughput of long chromatographic methods by using a novel Dual LC workflow

Application Note. Authors. Abstract. Food

Determination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography

Achiral SFC: Development of an Orthogonal SFC Method for Mometasone Furoate Impurity Analysis

Impact of Chromatography on Lipid Profiling of Liver Tissue Extracts

MS/MS Library Creation of Q-TOF LC/MS Data for MassHunter PCDL Manager

Analysis of Common Sweeteners and Additives in Beverages with the PerkinElmer Flexar FX-15 System Equipped with a PDA Detector

Application Note. Separation of clindamycin phosphate and process impurities. Summary. Introduction. Category Pharmaceutical analysis Matrix

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

Mass Spectrometry. Actual Instrumentation

Ultra High Performance Liquid Chromatograph. Nexera X2 C196-E079

Comparison of Relative Quantification of Monoclonal Antibody N-glycans Using Fluorescence and MS Detection

Thermo Scientific. GlycanPac AXR-1. Column Product Manual. P/N: April, Part of Thermo Fisher Scientific

Analysis of Isoflavones with the PerkinElmer Flexar FX-15 UHPLC System Equipped with a PDA Detector

Transcription:

Application Note Small Molecule Pharmaceutical Chiral Screening for SFC and UHPLC with the Agilent 16 Infinity II SFC/UHPLC Hybrid System Author Edgar Naegele, Agilent Technologies, Inc. Waldbronn, Germany Abstract This Application Note demonstrates the use of an Agilent 16 Infinity II SFC/UHPLC Hybrid System for fast method development in SFC and UHPLC mode by means of the Agilent Method Scouting Wizard software. As an example, a series of racemic pharmaceutical mixtures was screened using columns with identical chiral stationary phases in SFC and UHPLC mode, and the results of separations compared. 1 1 8 6 4 Cl N H 6.64 7.18 1 3 4 5 6 7 8 9 H 4 3 H 3 C H 4.37 4.649 1 1 3 4 5

Introduction The modern 16 Infinity II SFC/UHPLC Hybrid System can be operated robustly and reliably in SFC or UHPLC mode with the same level of performance as standalone SFC and UHPLC systems. This enables switching between SFC and UHPLC modes within one sequence of samples 1. Commonly, standalone SFC and UHPLC instruments are used for software-aided method scouting during development of analytical separation methods. Modern SFC/UHPLC hybrid systems could be used for this task in both modes. This provides an economical approach to collect initial scouting data for the analytical method development process. This Application Note demonstrates the use of the 16 Infinity II SFC/UHPLC Hybrid System in analytical method development with software aided method scouting in SFC and UHPLC mode. As an example, the fast scouting of different chiral compounds (Figure 1) using several combinations of chiral columns and solvents is presented, and subsequent method optimization is discussed. H 3 C N Experimental Instrumentation Figure 1. Chiral compounds used in this study (the asterisk indicates the chiral center). Agilent 16 Infinity II SFC/UHPLC Hybrid System comprises: Agilent 16 Infinity II SFC Control Module (G431A) Agilent 16 Infinity II SFC Binary Pump (G478A) Agilent 16 Infinity II SFC Multisampler (G4767A) Agilent 16 Infinity II Diode Array Detector (G7115A) with High Pressure SFC Flow Cell (G431-61). Two Agilent 19 Infinity II Multicolumn Thermostats (MCT) (G7116B) with Agilent InfinityLab Quick Change 8-Position/18-Port Valve (G439C) H H Cl N H H Agilent 16 Infinity II Quaternary Pump (G7111B) or Agilent 16 Infinity II Binary Pump (G711B; these will be subsequently referred to as the UHPLC pump ) Agilent 19 Infinity Valve Drive (G117A) with Agilent InfinityLab Quick Change -Position/1-Port Valve (G43C) Agilent 19 Infinity Valve Drive (G117A) with Agilent InfinityLab Quick Change 4-Position/1-Port 4-Column Selector Valve Head (G437A) Three Agilent 19 Infinity Valve Drives (G117A) with Agilent InfinityLab Quick Change 1-Position/13-Port Solvent Selector Valve Head (G435A) H

Instrumental setup A For the conversion of the 16 Infinity II SFC System into the 16 Infinity II SFC/UHPLC Hybrid System, a quaternary or binary UHPLC pump is added. This is connected by an InfinityLab Quick Change -Position/1 Port Valve, which allows direct switching between SFC and UHPLC modes (Figure ). Additionally, the described system is equipped with two MCTs. They are connected to the system with an InfinityLab Quick Change 4-Position/1-Port 4-Column Selector Valve for switching between the two MCTs (with one position for bypass). ne MCT is used for SFC columns and the other for UHPLC columns. Each MCT contains an InfinityLab Quick Change 8-Position/18-Port 8-Column Selector Valve (not shown in Figure ). For solvent selection, the SFC pump is clustered with an InfinityLab Quick Change 1-Position/13-Port Solvent Selector Valve at channel B. The UHPLC pump is also connected with two InfinityLab Quick Change 1-Position/13 Port Solvent Selector Valve heads on channels A and B. The central features, as outlined in Figure, are the plumbing at the InfinityLab Quick Change -Position/1 Port Valve and the plumbing at the InfinityLab Quick Change 4-Position/1-Port Valve. The position of the valve shown in Figure A connects the SFC Binary Pump and the SFC Control Module to the shared modules of the instrument. The position at the InfinityLab Quick Change 4-Position/1 Port Valve connects to MCT 1, which hosts the SFC columns. After flowing through the autosampler, the MCT with the SFC columns, and the detector, the C stream is connected back to the SFC Control Module for backpressure regulation. In this position, the UHPLC pump is connected to the waste. Waste 1 3 1 9 4 UT 1 3 3 8 4 4 a. DAD 1 7 b. 5 6 MCT MCT 1 SFC Multisampler a. b. UHPLC Pump Waste SFC Pump SFC/UHPLC-Hybrid System SFC Control Module B Waste 1 3 1 9 4 UT 1 3 3 8 4 4 a. 1 DAD b. 5 MCT MCT 1 SFC Multisampler 7 6 a. b. UHPLC Pump SFC Pump SFC/UHPLC-Hybrid System Waste SFC Control Module Figure. Instrumental setup of the Agilent 16 Infinity II SFC/UHPLC Hybrid System. A) SFC mode: the InfinityLab Quick Change -Position/1-Port Valve (b.) connects the SFC Control Module and the SFC Binary Pump to the shared modules. The InfinityLab Quick Change 4-Position/1-Port Valve (a.) connects MCT 1 with the SFC columns (contains an InfinityLab Quick Change 8-Position/18-Port 8-Column Selector Valve). B) UHPLC mode: the InfinityLab Quick Change -Position/1-Port Valve (b.) connects the UHPLC pump to the shared modules. The InfinityLab Quick Change 4-Position/1-Port Valve (a.) connects MCT with the UHPLC column (contains an InfinityLab Quick Change 8-Position/18-Port Valve 8-Column Selector Valve). 3

After switching the InfinityLab Quick Change -Position/1-Port Valve to the UHPLC position and the InfinityLab Quick Change 4-Position/1-Port Valve to MCT, which hosts the UHPLC columns, the UHPLC pump is connected to the shared modules (Figure B). To maintain backpressure, the SFC Binary Pump is directly connected to the SFC Control Module. For solvent selection, the SFC Binary Pump is clustered with an InfinityLab Quick Change 1-Position/13-Port Solvent Selection Valve at channel B. The UHPLC pump is also connected with two InfinityLab Quick Change 1-Position/13 Port Solvent Selector Valves on channels A and B. The described SFC/UHPLC hybrid system could be enhanced by up to four MCTs for 3 columns. f course, this cannot be built up in one stack of modules. In this case, two stacks of modules are necessary. Such a system would require an Agilent InfinityLab Quick Change 6-Position/14-Port Valve for the selection of the MCTs (Figure 3). Valve Valve Column 19 Infinity Valve Drive (G117A) 6-Position/14-Port Valve (G434C) Flow paths 1: MCT1 : MCT 3: MCT3 4: MCT4 5: bypass 6: waste Up to four 19 Infinity II MCTs (G7116B) + mounted 8-Position/18-Port 8-Column Solvent Selector Valve Heads (G439C) Position 1-8 Position 1-8 Position 1-8 Position 1-8 Figure 3. General setup of an MCT cluster: up to four MCTs hosting 3 columns. The MCTs are accessed by an InfinityLab Quick Change 6-Position/14-Port Valve, and inside each MCT there is an InfinityLab Quick Change 8-Position/18-Port 8-Column Selector Valve for final column selection. All valves are switched automatically to the correct position by choosing the desired column in the analytical method. 4

Columns (one set for SFC mode in MCT 1 and one set for UHPLC mode in MCT ) InfinityLab Poroshell 1 Chiral CF, 4.6 1 mm,.7 µm (p/n 685975 69) InfinityLab Poroshell 1 Chiral CD, 4.6 1 mm,.7 µm (p/n 685975 67) InfinityLab Poroshell 1 Chiral-V, 4.6 1 mm,.7 µm (p/n 685975-64) InfinityLab Poroshell 1 Chiral-T, 4.6 1 mm,.7 µm (p/n 685975-63) Software Agilent penlab CDS ChemStation Edition for LC & LC/MS Systems, Rev. C.1.8 Method Scouting Wizard Rev. A.8.11 Software setup For the generation of different methods of separation screening in SFC and UHPLC mode, the Method Scouting Wizard was used. n the first page of the Method Scouting Wizard, the pump was chosen according to the mode used for the screening. Solvents, columns, and gradient separation conditions were then set up. Finally, all necessary separation methods as well as flushing and equilibration methods were generated and executed automatically by the Method Scouting Wizard. For data evaluation, Method Scouting Reports, which are integrated in ChemStation Intelligent Reporting, were used to filter the successful separations by resolution. SFC starting conditions Parameter Solvent A C Modifier B Samples, ketoprofen, ibuprofen, indoprofen, each 1 mg/ml in methanol. Chemicals All solvents were purchased from Merck, Germany. Fresh ultrapure water was obtained from a Milli-Q integral system equipped with LC-Pak polisher and a.-µm membrane point of use cartridge (Millipak). Chemicals were purchased from Sigma-Aldrich (Germany). Value Methanol +.1 % TEA/.1 % TFA Ethanol +.1 % TEA/.1 % TFA Isopropanol +.1 % TEA/.1 % TFA SFC flow Gradient ml/ utes to 1 % B, 1 utes to 5 % B Backpressure regulator (BPR) temperature 6 C BPR pressure 14 bar Column temperature 3 C Injection volume. µl Feed solvent methanol ver feed volume 4 µl Feed speed Needle wash 4 µl/ 3 seconds in methanol UHPLC starting conditions Parameter Value Solvent A Water + 15 mm ammonium formate, ph 4. Solvent B Flow rate Isocratic Acetonitrile.5 ml/ 3, 4, 5 %B Stop time: 1 utes Column temperature 3 C Injection volume 1. µl Needle wash 3 seconds in methanol 5

Results and Discussion Method scouting and method optimization in SFC mode For the initial scouting runs, a short 1 ute gradient run with modifier concentration of 1 to 5 % was applied at a column temperature of 3 C in SFC mode. Four different chiral columns were screened against three solvents (methanol, ethanol, and isopropanol, each with.1 % TEA/TFA). nly methanol as modifier could resolve the enantiomers of the chiral test mixtures using different chiral columns. For a brief overview, the Method Scouting Report, which shows the achieved resolution in bubble charts, was used (Figure 4). The bubble chart report shows that all compounds start to separate under the initial scouting conditions on the InfinityLab Poroshell 1 Chiral-T column (more detailed information is outlined in Table 1). Table 1. Results of the initial chiral screening separation by means of SFC on four different chiral columns with methanol (.1 % TEA/TFA) as modifier. Peaks RT Resolution Symmetry Column 3.867 4.33.1.86.69 Poroshell 1 Chiral-CD 1.49.8 Poroshell 1 Chiral-CF 1 4.84.64 Poroshell 1 Chiral-V 3.585 3.731 1.63.9.8 Poroshell 1 Chiral-T 1 1.489.68 Poroshell 1 Chiral-CD 1 1.5.87 Poroshell 1 Chiral-CF 1 1.8.91 Poroshell 1 Chiral-V 1.797 1.855.65 1.8.79 Poroshell 1 Chiral-T 1 1.17.63 Poroshell 1 Chiral-CD 1.87 1.18 Poroshell 1 Chiral-CF 1 1.8 1.5 Poroshell 1 Chiral-V 1.67 1.17 3.467 3.535.5.66 1.8.67.94.64 Poroshell 1 Chiral-T Poroshell 1 Chiral-CD 1.149.95 Poroshell 1 Chiral-CF 3.99 4.75 1.3.81.65 Poroshell 1 Chiral-V 3.87 4.8 1.9.71.63 Poroshell 1 Chiral-T 5.3 1. 4.6 1.14 3.98 3.35 1.6.98.7.9.9 1 3 4 1 3 4 1.96 1.79 1.6 1.46 1.9 1.1 1 3 4 3.88 3.37.85.34 1.83 1 3 4 Figure 4. Brief overview of resolution achieved in the SFC scouting runs. The bubble size shows the maximum resolution sum achieved for each compound and column combination. The retention time of the compounds is given on the Y-axis. Columns: 1) InfinityLab Poroshell 1 Chiral-CD; ) InfinityLab Poroshell 1 Chiral-CF; 3) InfinityLab Poroshell 1 Chiral-V; 4) InfinityLab Poroshell 1 Chiral-T. 6

The enantiomers of carprofen and indoprofen separate on other phases as well. The carprofen enantiomers in particular separate well on the InfinityLab Poroshell 1 Chiral CD column (Figure 5A). Figure 5B shows the separation of the indoprofen enantiomers on the InfinityLab Poroshell 1 Chiral-T column. The initial screening took approximately three and a half hours for all compounds and columns combined with one solvent. For further optimization of the separation, isocratic separation conditions were tested with the InfinityLab Poroshell 1 Chiral-T column. Figures 6A and 6B respectively show isocratic separations of carprofen and indoprofen enantiomers on this column. The ketoprofen racemic mixture could only be separated with lower resolution under the tested conditions. 4 3 A Cl N H H 3.867 4.33 15 15 1 75 B N H 3.87 4.8 1 5 5 1 3 4 5 1 3 4 5 6 Figure 5. Separation of enantiomers of A) carprofen (InfinityLab Poroshell 1 Chiral-CD) and B) indoprofen (InfinityLab Poroshell 1 Chiral-T) under initial SFC chiral screening conditions. 1 A 6.64 7.18 8 B 3.91 4.33 1 8 6 6 4 4 1 3 4 5 6 7 8 9 1 3 4 5 6 7 Figure 6. Separation of enantiomers of A) carprofen (InfinityLab Poroshell 1 Chiral-T, isocratic, 1 %B) and B) indoprofen (InfinityLab Poroshell 1 Chiral-T, isocratic, 15 %B). 7

Method scouting and method optimization in UHPLC mode Under UHPLC conditions, three different mobile phases (methanol, 3, 4, and 5 %, with 15 mm ammonium formate at ph 4.) were screened against the four racemic test mixtures and the InfinityLab Poroshell 1 Chiral-T column. Bubble chart reports created from the results show the maximum resolution sum, and identify the best solvent for the separation of each compound together with the maximum retention time on the given column (Figure 7). Table summarizes the detailed results. To optimize the separation, which was achieved with a level of 4 % methanol, the temperature was decreased from 3 to C (Table 3). 7.4 7.1 6.45 5.88 4.64 5.48 4.5 3.39 3.55.15 1 3 1 3 8.6 6.7 5.35 4..64 7.5 6.7 5.3 3.78.53 1 3 1 3 Figure 7. Brief overview of resolution achieved in UHPLC scouting runs. The bubble size shows the maximum resolution sum achieved for each compound and solvent on the InfinityLab Poroshell 1 Chiral-T column. Solvents: 1) 3 % methanol; ) 4 % methanol; and 3) 5 % methanol, each with 15 mm ammonium formate at ph 4.. Table. Results of the initial chiral screening separation by means of UHPLC mode of the four racemic mixtures with three solvents on one chiral column at 3 C. 3 % methanol 4 % methanol 5 % methanol Table 3. Temperature optimization of the separation achieved with 4 % methanol on the InfinityLab Poroshell 1 Chiral-T column. RT Resolution Symmetry RT Resolution Symmetry RT Resolution Symmetry RT Resolution Symmetry 6.33 6.811 8.7 8.566 1.83.99.49.44.7.56 7.184 7.66 3.83 4.57 5.851 5.989 7.358 7.9 1.37 1.65.64 1.71.6.53.84.78 1.3.66.57.49 4.149 4.318 3.67 3.187 3.465 5.584 5.85 1.6 1.6 1.49.85.71.95.91.79.7 8.8 8.857 4.37 4.649 6.379 6.566 8.783 9.645 1.48.3.7 1.98.56.51.83.7.91.66.63.64 8

Figure 8 shows, as an example, the separation finally achieved for ibuprofen enantiomers. The ketoprofen racemic mixture could only be separated with insufficient resolution under the tested conditions. Conclusion This Application Note demonstrates the use of an enhanced 16 Infinity II SFC/UHPLC Hybrid System for combined method development in SFC and UHPLC modes for chiral screening. This system can host up to 16 columns, up to 1 solvents for SFC, and up to 4 solvents for UHPLC separations. By means of four MCTs, it is possible to use up to 3 columns. The methods necessary for the screening were created with the aid of the Method Scouting Wizard software. It was shown that a set of racemic mixtures could be separated into their component enantiomers by means of the same InfinityLab Poroshell 1 chiral columns in SFC mode as well as UHPLC mode. After a short optimization of the screening results, a good method for separation of the enantiomers under isocratic conditions could be achieved. The applied concept of chiral screening was recently realized by a high throughput walk-up system running in a pharmaceutical environment 3. 4.37 4 H 3 C 4.649 3 H 1 1 3 4 5 Figure 8. Separation of the enantiomers of ibuprofen under UHPLC conditions. 9

References 1. rthogonal Separations Using the Agilent 16 Infinity II SFC/UHPLC Hybrid System, Agilent Technologies Technical verview, publication number 5991-876EN.. Chiral Multicolumn Method Development on the Agilent 16 Infinity II Analytical SFC System, Agilent Technologies Application Note, publication number 5991 764EN. 3. Easy Access to Rapid Chiral SFC Method Development for NonChromatographers, Agilent Technologies Application Note, publication number 5994 11EN. www.agilent.com/chem This information is subject to change without notice. Agilent Technologies, Inc. 18 Printed in the USA, September 1, 18 5994-171EN